Schryver Medical, a portfolio company of Revelstoke Capital Partners, has acquired B.O.N. Clinical Laboratories (BON Labs).
BON Labs provides laboratory services to medical facilities and to offices of physicians. The company has laboratories in Henderson, NV, and Burbank, CA. The laboratories are licensed with a CLIA (Clinical Laboratory Improvement Amendments) High Complexity certification and are participating providers for Medicare, Medicaid, and MediCal insurance plans. The company is headquartered just south of Las Vegas in Henderson, NV (www.bonlaboratories.com).
Schryver Medical, acquired by Revelstoke in July 2014, is a provider of mobile imaging diagnostics, clinical laboratory services, oxygen therapy and medical equipment rental. Schryver serves nearly 3,000 long term post-acute facilities, assisted-living centers, and skilled nursing facilities, as well as numerous homecare patients. The company has approximately 500 employees and is headquartered in Denver (www.schryvermedical.com).
The buy of BON Labs is the fourth add-on acquisition completed by Schryver in 2015. In July 2015, the company completed the acquisitions of Main Street Clinical Laboratory and On-Site Imaging Solutions. These two acquisitions followed Schryver’s January 2015 acquisition of Nashville-based Quality Mobile X-Ray. “We are excited to expand our operations in the Southwest,” said Doug Goetz, CEO of Schryver. “Rapid response times combined with the highest quality diagnostic services are critical to our customers, and adding BON’s allows us to better serve our current and new customers on the Pacific Coast.”
Revelstoke invests from $10 million to $250 million in companies that have at least $5 million of EBITDA. Sectors of interest include healthcare services and products; transportation and logistics; specialty distribution; energy and energy services; building products; business and outsourced services; marketing services; financial services; industrial services; and medical technology. The firm is headquartered in Denver (www.revelstokecp.com).
“The resources, expertise, and strategy that Schryver has leveraged in building its reputation as a market leader will translate into continued success and we are pleased by the Schryver team’s continued ability to identify and integrate add-on opportunities,” said Mark King, CEO, Managing Partner and Co-Founder of Revelstoke.
© 2015 PEPD • Private Equity’s Leading News Magazine • 8-25-15
